Equities
Health CareMedical Equipment and Services
  • Price (AUD)32.54
  • Today's Change0.52 / 1.62%
  • Shares traded306.98k
  • 1 Year change+43.16%
  • Beta0.7760
Data delayed at least 20 minutes, as of Nov 08 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy1
Outperform3
Hold5
Sell1
Strong Sell0

Share price forecast in USD

The 10 analysts offering 12 month price targets for Ansell Ltd have a median target of 31.54, with a high estimate of 37.92 and a low estimate of 24.94. The median estimate represents a -3.09% decrease from the last price of 32.54.
High16.5%37.92
Med-3.1%31.54
Low-23.3%24.94

Dividends in USD

In 2024, Ansell Ltd reported a dividend of 0.38 USD, which represents a 17.23% decrease from last year. The 9 analysts covering the company expect dividends of 0.49 USD for the upcoming fiscal year, an increase of 28.65%.
Div growth (TTM)-17.23%
More ▼

Earnings history & estimates in USD

Ansell Ltd reported annual 2024 earnings of 1.02 per share on Aug 19, 2024.
Average growth rate+1.18%
More ▼

Revenue history & estimates in USD

Ansell Limited had revenues for the full year 2024 of 1.62bn. This was 2.16% below the prior year's results.
Average growth rate+1.13%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.